Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$401M |
| 2 |
NVIDIA
NVDA
|
$333M |
| 3 |
Costco
COST
|
$236M |
| 4 |
Amazon
AMZN
|
$215M |
| 5 |
Johnson & Johnson
JNJ
|
$160M |
Top Sells
| 1 |
Broadcom
AVGO
|
$322M |
| 2 |
Super Micro Computer
SMCI
|
$284M |
| 3 |
JPMorgan Chase
JPM
|
$178M |
| 4 |
WIRE
Encore Wire Corp
WIRE
|
$160M |
| 5 |
Intel
INTC
|
$152M |
Sector Composition
| 1 | Technology | 19.73% |
| 2 | Financials | 17.51% |
| 3 | Industrials | 12.49% |
| 4 | Consumer Discretionary | 10.71% |
| 5 | Healthcare | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Alpha Teknova
TKNO
$233M
| $86.1K | ﹤0.01% |
17,855
-1,271
| -7% | -$6.13K |
|
3252
Eledon Pharmaceuticals
ELDN
$162M
| $85.2K | ﹤0.01% |
34,223
+3,990
| +13% | +$9.94K |
|
|
SOHO
3253
Sotherly Hotels
SOHO
$17M
| $84K | ﹤0.01% |
69,421
-5,127
| -7% | -$6.2K |
|
3254
Astrotech Corp
ASTC
$8.47M
| $83.8K | ﹤0.01% |
10,351
-931
| -8% | -$7.54K |
|
3255
Lipocine
LPCN
$15.7M
| $80.9K | ﹤0.01% |
18,016
+6,146
| +52% | +$27.6K |
|
3256
INmune Bio
INMB
$51.8M
| $79K | ﹤0.01% |
+14,648
| New | +$79K |
|
3257
Copel
ELPC
$6.21B
| $78.7K | ﹤0.01% |
12,279
+359
| +3% | +$2.3K |
|
|
ICAD
3258
DELISTED
iCAD Inc
ICAD
| $77K | ﹤0.01% |
49,099
| – | – |
|
3259
Assertio
ASRT
$76.8M
| $75.9K | ﹤0.01% |
64,304
| – | – |
|
3260
Lightpath Technologies
LPTH
$243M
| $74.7K | ﹤0.01% |
54,543
| – | – |
|
3261
Solid Power
SLDP
$760M
| $74.1K | ﹤0.01% |
54,878
-27,980
| -34% | -$37.8K |
|
3262
Dominari Holdings
DOMH
$90.9M
| $73.7K | ﹤0.01% |
39,833
| – | – |
|
|
WHWK
3263
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.8M
| $73.2K | ﹤0.01% |
35,595
-61
| -0.2% | -$125 |
|
3264
Tenax Therapeutics
TENX
$27.4M
| $72.7K | ﹤0.01% |
+21,006
| New | +$72.7K |
|
|
IMAB
3265
I-MAB
IMAB
$358M
| $72.4K | ﹤0.01% |
58,358
| – | – |
|
3266
ThredUp
TDUP
$1.43B
| $72.2K | ﹤0.01% |
85,513
-48,084
| -36% | -$40.6K |
|
3267
DiaMedica Therapeutics
DMAC
$317M
| $71.1K | ﹤0.01% |
16,959
| – | – |
|
3268
ALX Oncology
ALXO
$65.3M
| $68.8K | ﹤0.01% |
37,646
+3,103
| +9% | +$5.67K |
|
3269
Skillz
SKLZ
$114M
| $68.6K | ﹤0.01% |
12,201
+4
| +0% | +$22 |
|
|
IMA
3270
ImageneBio, Inc. Common Stock
IMA
$89M
| $66.8K | ﹤0.01% |
3,218
| – | – |
|
3271
MEI Pharma
MEIP
$139M
| $66.8K | ﹤0.01% |
23,427
+6,855
| +41% | +$19.5K |
|
3272
Sphere 3D
ANY
$18.3M
| $66.3K | ﹤0.01% |
73,260
| – | – |
|
|
VXRT
3273
DELISTED
Vaxart
VXRT
| $64.1K | ﹤0.01% |
75,491
| – | – |
|
3274
SOPHiA GENETICS
SOPH
$219M
| $63.9K | ﹤0.01% |
17,504
+5,150
| +42% | +$18.8K |
|
3275
Usio Inc
USIO
$37.4M
| $63.1K | ﹤0.01% |
46,421
| – | – |
|